Literature DB >> 25355872

High-throughput RNA sequencing-based virome analysis of 50 lymphoma cell lines from the Cancer Cell Line Encyclopedia project.

Subing Cao1, Michael J Strong1, Xia Wang1, Walter N Moss2, Monica Concha1, Zhen Lin1, Tina O'Grady1, Melody Baddoo1, Claire Fewell1, Rolf Renne3, Erik K Flemington4.   

Abstract

UNLABELLED: Using high-throughput RNA sequencing data from 50 common lymphoma cell culture models from the Cancer Cell Line Encyclopedia project, we performed an unbiased global interrogation for the presence of a panel of 740 viruses and strains known to infect human and other mammalian cells. This led to the findings of previously identified infections by Epstein-Barr virus (EBV), Kaposi's sarcoma herpesvirus (KSHV), and human T-lymphotropic virus type 1 (HTLV-1). In addition, we also found a previously unreported infection of one cell line (DEL) with a murine leukemia virus. High expression of murine leukemia virus (MuLV) transcripts was observed in DEL cells, and we identified four transcriptionally active integration sites, one being in the TNFRSF6B gene. We also found low levels of MuLV reads in a number of other cell lines and provided evidence suggesting cross-contamination during sequencing. Analysis of HTLV-1 integrations in two cell lines, HuT 102 and MJ, identified 14 and 66 transcriptionally active integration sites with potentially activating integrations in immune regulatory genes, including interleukin-15 (IL-15), IL-6ST, STAT5B, HIVEP1, and IL-9R. Although KSHV and EBV do not typically integrate into the genome, we investigated a previously identified integration of EBV into the BACH2 locus in Raji cells. This analysis identified a BACH2 disruption mechanism involving splice donor sequestration. Through viral gene expression analysis, we detected expression of stable intronic RNAs from the EBV BamHI W repeats that may be part of long transcripts spanning the repeat region. We also observed transcripts at the EBV vIL-10 locus exclusively in the Hodgkin's lymphoma cell line, Hs 611.T, the expression of which were uncoupled from other lytic genes. Assessment of the KSHV viral transcriptome in BCP-1 cells showed expression of the viral immune regulators, K2/vIL-6, K4/vIL-8-like vCCL1, and K5/E2-ubiquitin ligase 1 that was significantly higher than expression of the latency-associated nuclear antigen. Together, this investigation sheds light into the virus composition across these lymphoma model systems and provides insights into common viral mechanistic principles. IMPORTANCE: Viruses cause cancer in humans. In lymphomas the Epstein-Barr virus (EBV), Kaposi's sarcoma herpesvirus (KSHV) and human T-lymphotropic virus type 1 are major contributors to oncogenesis. We assessed virus-host interactions using a high throughput sequencing method that facilitates the discovery of new virus-host associations and the investigation into how the viruses alter their host environment. We found a previously unknown murine leukemia virus infection in one cell line. We identified cellular genes, including cytokine regulators, that are disrupted by virus integration, and we determined mechanisms through which virus integration causes deregulation of cellular gene expression. Investigation into the KSHV transcriptome in the BCP-1 cell line revealed high-level expression of immune signaling genes. EBV transcriptome analysis showed expression of vIL-10 transcripts in a Hodgkin's lymphoma that was uncoupled from lytic genes. These findings illustrate unique mechanisms of viral gene regulation and to the importance of virus-mediated host immune signaling in lymphomas.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25355872      PMCID: PMC4301145          DOI: 10.1128/JVI.02570-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus.

Authors:  Chih-Chung Lu; Yi-Ying Jeng; Ching-Hwa Tsai; Mei-Ying Liu; Sheng-Wen Yeh; Tsuey-Ying Hsu; Mei-Ru Chen
Journal:  Virology       Date:  2005-11-18       Impact factor: 3.616

2.  Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines.

Authors:  H J Delecluse; S Bartnizke; W Hammerschmidt; J Bullerdiek; G W Bornkamm
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

3.  RNA encoded by the IR1-U2 region of Epstein-Barr virus DNA in latently infected, growth-transformed cells.

Authors:  V van Santen; A Cheung; M Hummel; E Kieff
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

4.  Evidence for integrated EBV genomes in Raji cellular DNA.

Authors:  M Anvret; A Karlsson; G Bjursell
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

5.  Recombinant origin of the retrovirus XMRV.

Authors:  Tobias Paprotka; Krista A Delviks-Frankenberry; Oya Cingöz; Anthony Martinez; Hsing-Jien Kung; Clifford G Tepper; Wei-Shau Hu; Matthew J Fivash; John M Coffin; Vinay K Pathak
Journal:  Science       Date:  2011-05-31       Impact factor: 47.728

6.  Detection of murine leukemia virus in the Epstein-Barr virus-positive human B-cell line JY, using a computational RNA-Seq-based exogenous agent detection pipeline, PARSES.

Authors:  Zhen Lin; Adriane Puetter; Joseph Coco; Guorong Xu; Michael J Strong; Xia Wang; Claire Fewell; Melody Baddoo; Christopher Taylor; Erik K Flemington
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

7.  Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in human and other primate cell lines.

Authors:  Cord C Uphoff; Sabine A Denkmann; Klaus G Steube; Hans G Drexler
Journal:  J Biomed Biotechnol       Date:  2010-04-29

8.  Comprehensive high-throughput RNA sequencing analysis reveals contamination of multiple nasopharyngeal carcinoma cell lines with HeLa cell genomes.

Authors:  Michael J Strong; Melody Baddoo; Asuka Nanbo; Miao Xu; Adriane Puetter; Zhen Lin
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

9.  Transmissible retrovirus in Epstein-Barr virus-producer B95-8 cells.

Authors:  R Sun; E Grogan; D Shedd; A F Bykovsky; V M Kushnaryov; S E Grossberg; G Miller
Journal:  Virology       Date:  1995-06-01       Impact factor: 3.616

10.  Complexities associated with expression of Epstein-Barr virus (EBV) lytic origins of DNA replication.

Authors:  Shao-An Xue; Beverly E Griffin
Journal:  Nucleic Acids Res       Date:  2007-05-03       Impact factor: 16.971

View more
  43 in total

1.  Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.

Authors:  Aron R Marquitz; Anuja Mathur; Rachel Hood Edwards; Nancy Raab-Traub
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  Latent Expression of the Epstein-Barr Virus (EBV)-Encoded Major Histocompatibility Complex Class I TAP Inhibitor, BNLF2a, in EBV-Positive Gastric Carcinomas.

Authors:  Michael J Strong; Thomas Laskow; Hani Nakhoul; Eugene Blanchard; Yaozhong Liu; Xia Wang; Melody Baddoo; Zhen Lin; Qinyan Yin; Erik K Flemington
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

3.  New Noncoding Lytic Transcripts Derived from the Epstein-Barr Virus Latency Origin of Replication, oriP, Are Hyperedited, Bind the Paraspeckle Protein, NONO/p54nrb, and Support Viral Lytic Transcription.

Authors:  Subing Cao; Walter Moss; Tina O'Grady; Monica Concha; Michael J Strong; Xia Wang; Yi Yu; Melody Baddoo; Kun Zhang; Claire Fewell; Zhen Lin; Yan Dong; Erik K Flemington
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

Review 4.  Cancer whole-genome sequencing: present and future.

Authors:  H Nakagawa; C P Wardell; M Furuta; H Taniguchi; A Fujimoto
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

5.  Quantitative Analysis of the KSHV Transcriptome Following Primary Infection of Blood and Lymphatic Endothelial Cells.

Authors:  A Gregory Bruce; Serge Barcy; Terri DiMaio; Emilia Gan; H Jacques Garrigues; Michael Lagunoff; Timothy M Rose
Journal:  Pathogens       Date:  2017-03-19

6.  Genomic Landscapes of Epstein-Barr Virus in Pulmonary Lymphoepithelioma-Like Carcinoma.

Authors:  Yan-Xia Wu; Wen-Li Zhang; Tong-Min Wang; Ying Liao; Yi-Jun Zhang; Ruo-Wen Xiao; Yi-Jing Jia; Zi-Yi Wu; Chang-Mi Deng; Da-Wei Yang; Wen-Qiong Xue; Yong-Qiao He; Xiao-Hui Zheng; Xi-Zhao Li; Ting Zhou; Pei-Fen Zhang; Shao-Dan Zhang; Ye-Zhu Hu; Jiang-Bo Zhang; Wei-Hua Jia
Journal:  J Virol       Date:  2021-12-15       Impact factor: 6.549

7.  Epstein-Barr virus latency type and spontaneous reactivation predict lytic induction levels.

Authors:  An T Phan; Samantha G Fernandez; Jessica J Somberg; Kristin M Keck; Jj L Miranda
Journal:  Biochem Biophys Res Commun       Date:  2016-04-16       Impact factor: 3.575

Review 8.  Roles of Non-coding RNAs During Herpesvirus Infection.

Authors:  Meaghan H Hancock; Rebecca L Skalsky
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

Review 9.  The role of HIV integration in viral persistence: no more whistling past the proviral graveyard.

Authors:  Frank Maldarelli
Journal:  J Clin Invest       Date:  2016-02-01       Impact factor: 14.808

Review 10.  Pathogenic Role of Epstein-Barr Virus in Lung Cancers.

Authors:  David Becnel; Ramsy Abdelghani; Asuka Nanbo; Janardhan Avilala; Jacob Kahn; Li Li; Zhen Lin
Journal:  Viruses       Date:  2021-05-11       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.